Reto Stöcklin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Reto Stöcklin has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Philippe Bulet
CR University Grenoble Alpes, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, 38000 Grenoble, France
3 shared publications - Philippe Favreau
Atheris Laboratories, Case postale 314, CH-1233 Bernex-Geneva, Switzerland
3 shared publications - Dimitri Noukakis
EPFL VPRI, Lausanne, Switzerland
2 shared publications Philippe Favreau
2 shared publicationsRobert Thai
2 shared publications- Adrijana Leonardi
Department of Molecular and Biomedical Sciences, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia
1 shared publication
Latest Publications
- 1 April 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1834 (4) , 717-724
Position-specific scoring matrix and hidden Markov model complement each other for the prediction of conopeptide superfamilies
- 1 April 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1834 (4) , 717-724
Position-specific scoring matrix and hidden Markov model complement each other for the prediction of conopeptide superfamilies
- Open Access
- 1 March 2013
- Published by MDPI AG in Marine Drugs
- Vol. 11 (3) , 623-642
Glycosylation of Conotoxins
Conotoxins are small peptides present in the venom of cone snails. The snail uses this venom to paralyze and capture prey. The constituent conopeptides display a high level of chemical diversity and are of particular interest for scientists as tools employed in neurological studies and for drug development, because they target with exquisite specificity membrane receptors, transporters, and various ion channels in the nervous system. However, these peptides are known to contain a high frequency and variability of post-translational modifications—including sometimes O-glycosylation—which are of importance for biological activity. The potential application of specific conotoxins as neuropharmalogical agents and chemical probes requires a full characterization of the relevant peptides, including the structure of the carbohydrate part. In this review, the currently existing knowledge of O-glycosylation of conotoxins is described.
- 1 March 2013
- Published by MDPI AG in Marine Drugs
- Vol. 11 (3) , 623-642
Open AccessGlycosylation of Conotoxins
Conotoxins are small peptides present in the venom of cone snails. The snail uses this venom to paralyze and capture prey. The constituent conopeptides display a high level of chemical diversity and are of particular interest for scientists as tools employed in neurological studies and for drug development, because they target with exquisite specificity membrane receptors, transporters, and various ion channels in the nervous system. However, these peptides are known to contain a high frequency and variability of post-translational modifications—including sometimes O-glycosylation—which are of importance for biological activity. The potential application of specific conotoxins as neuropharmalogical agents and chemical probes requires a full characterization of the relevant peptides, including the structure of the carbohydrate part. In this review, the currently existing knowledge of O-glycosylation of conotoxins is described.
- Open Access
- 31 January 2012
- Published by MDPI AG in Marine Drugs
- Vol. 10 (2) , 258-280
Recruitment of Glycosyl Hydrolase Proteins in a Cone Snail Venomous Arsenal: Further Insights into Biomolecular Features of Conus Venoms
Cone snail venoms are considered an untapped reservoir of extremely diverse peptides, named conopeptides, displaying a wide array of pharmacological activities. We report here for the first time, the presence of high molecular weight compounds that participate in the envenomation cocktail used by these marine snails. Using a combination of proteomic and transcriptomic approaches, we identified glycosyl hydrolase proteins, of the hyaluronidase type (Hyal), from the dissected and injectable venoms (“injectable venom” stands for the venom variety obtained by milking of the snails. This is in contrast to the “dissected venom”, which was obtained from dissected snails by extraction of the venom glands) of a fish-hunting cone snail, Conus consors (Pionoconus clade). The major Hyal isoform, Conohyal-Cn1, is expressed as a mixture of numerous glycosylated proteins in the 50 kDa molecular mass range, as observed in 2D gel and mass spectrometry analyses. Further proteomic analysis and venom duct mRNA sequencing allowed full sequence determination. Additionally, unambiguous segment location of at least three glycosylation sites could be determined, with glycans corresponding to multiple hexose (Hex) and N-acetylhexosamine (HexNAc) moieties. With respect to other known Hyals, Conohyal-Cn1 clearly belongs to the hydrolase-type of Hyals, with strictly conserved consensus catalytic donor and positioning residues. Potent biological activity of the native Conohyals could be confirmed in degrading hyaluronic acid. A similar Hyal sequence was also found in the venom duct transcriptome of C. adamsonii (Textilia clade), implying a possible widespread recruitment of this enzyme family in fish-hunting cone snail venoms. These results provide the first detailed Hyal sequence characterized from a cone snail venom, and to a larger extent in the Mollusca phylum, thus extending our knowledge on this protein family and its evolutionary selection in marine snail venoms.
- 31 January 2012
- Published by MDPI AG in Marine Drugs
- Vol. 10 (2) , 258-280
Open AccessRecruitment of Glycosyl Hydrolase Proteins in a Cone Snail Venomous Arsenal: Further Insights into Biomolecular Features of Conus Venoms
Cone snail venoms are considered an untapped reservoir of extremely diverse peptides, named conopeptides, displaying a wide array of pharmacological activities. We report here for the first time, the presence of high molecular weight compounds that participate in the envenomation cocktail used by these marine snails. Using a combination of proteomic and transcriptomic approaches, we identified glycosyl hydrolase proteins, of the hyaluronidase type (Hyal), from the dissected and injectable venoms (“injectable venom” stands for the venom variety obtained by milking of the snails. This is in contrast to the “dissected venom”, which was obtained from dissected snails by extraction of the venom glands) of a fish-hunting cone snail, Conus consors (Pionoconus clade). The major Hyal isoform, Conohyal-Cn1, is expressed as a mixture of numerous glycosylated proteins in the 50 kDa molecular mass range, as observed in 2D gel and mass spectrometry analyses. Further proteomic analysis and venom duct mRNA sequencing allowed full sequence determination. Additionally, unambiguous segment location of at least three glycosylation sites could be determined, with glycans corresponding to multiple hexose (Hex) and N-acetylhexosamine (HexNAc) moieties. With respect to other known Hyals, Conohyal-Cn1 clearly belongs to the hydrolase-type of Hyals, with strictly conserved consensus catalytic donor and positioning residues. Potent biological activity of the native Conohyals could be confirmed in degrading hyaluronic acid. A similar Hyal sequence was also found in the venom duct transcriptome of C. adamsonii (Textilia clade), implying a possible widespread recruitment of this enzyme family in fish-hunting cone snail venoms. These results provide the first detailed Hyal sequence characterized from a cone snail venom, and to a larger extent in the Mollusca phylum, thus extending our knowledge on this protein family and its evolutionary selection in marine snail venoms.
- 8 January 2007
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 21 (3) , 406-412
The venom of the snake genus Atheris contains a new class of peptides with clusters of histidine and glycine residues
We investigated venoms from members of the genus Atheris (Serpentes, Viperidae), namely the rough scale bush viper ( Atheris squamigera ), the green bush viper ( A. chlorechis ) and the great lakes bush viper ( A. nitschei ), using mass spectrometry‐based strategies, relying on matrix‐assisted laser desorption/ionisation time‐of‐flight mass spectrometry (MALDI‐TOF‐MS) and electrospray ionisation tandem mass spectrometry (ESI‐MS/MS) with de novo peptide sequencing. We discovered a set of novel peptides with masses in the 2–3 kDa range and containing poly‐His and poly‐Gly segments (pHpG). Complete primary structural elucidation and confirmation of two sequences by Edman degradation indicated the consensus sequence EDDH (9) GVG (10) . Bioinformatic investigations in protein sequence databanks did not show relevant homology with known peptides or proteins. However, a more extensive investigation of data in nucleic acid databases revealed some similarities to the precursor sequences of bradykinin potentiating peptides (BPP) and C‐type natriuretic peptides (CNP), agents that are known to affect the cardiovascular system by acting on specific metalloproteases and receptors. The novel pHpG peptides found in Atheris venoms might also act on the cardiovascular system by inhibiting particular metalloproteases, which however remain to be identified. Copyright © 2007 John Wiley & Sons, Ltd.
- 8 January 2007
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 21 (3) , 406-412
The venom of the snake genus Atheris contains a new class of peptides with clusters of histidine and glycine residues
We investigated venoms from members of the genus Atheris (Serpentes, Viperidae), namely the rough scale bush viper ( Atheris squamigera ), the green bush viper ( A. chlorechis ) and the great lakes bush viper ( A. nitschei ), using mass spectrometry‐based strategies, relying on matrix‐assisted laser desorption/ionisation time‐of‐flight mass spectrometry (MALDI‐TOF‐MS) and electrospray ionisation tandem mass spectrometry (ESI‐MS/MS) with de novo peptide sequencing. We discovered a set of novel peptides with masses in the 2–3 kDa range and containing poly‐His and poly‐Gly segments (pHpG). Complete primary structural elucidation and confirmation of two sequences by Edman degradation indicated the consensus sequence EDDH (9) GVG (10) . Bioinformatic investigations in protein sequence databanks did not show relevant homology with known peptides or proteins. However, a more extensive investigation of data in nucleic acid databases revealed some similarities to the precursor sequences of bradykinin potentiating peptides (BPP) and C‐type natriuretic peptides (CNP), agents that are known to affect the cardiovascular system by acting on specific metalloproteases and receptors. The novel pHpG peptides found in Atheris venoms might also act on the cardiovascular system by inhibiting particular metalloproteases, which however remain to be identified. Copyright © 2007 John Wiley & Sons, Ltd.
- 7 October 2005
- Published by Wiley in Journal of Peptide Science
- Vol. 11 (11) , 669
Editorial
- 2 August 2005
- Published by Wiley in Proteomics
- Vol. 5 (12) , 3017-3018
Report of the roundtable discussion organised by the Swiss Proteomics Society (SPS), Bern, 8th December 2004
How close are we to using proteomics tools in the every day practice of physicians? What are the socio‐economical issues our health care system may face with the advent of biomarkers for early diagnosis? How to get the specialists from the various disciplines integrated in proteomics to establish a common understanding of the clinical issues and develop the necessary standards (methods, biochemicals and IT)? These were the kind of questions a panel of specialists tried to answer during the roundtable discussion that took place in Bern during the Swiss Proteomics Society 2004 congress.
- 2 August 2005
- Published by Wiley in Proteomics
- Vol. 5 (12) , 3017-3018
Report of the roundtable discussion organised by the Swiss Proteomics Society (SPS), Bern, 8th December 2004
How close are we to using proteomics tools in the every day practice of physicians? What are the socio‐economical issues our health care system may face with the advent of biomarkers for early diagnosis? How to get the specialists from the various disciplines integrated in proteomics to establish a common understanding of the clinical issues and develop the necessary standards (methods, biochemicals and IT)? These were the kind of questions a panel of specialists tried to answer during the roundtable discussion that took place in Bern during the Swiss Proteomics Society 2004 congress.